1 - biotechLAB

oculoplaniaballtownΒιοτεχνολογία

1 Δεκ 2012 (πριν από 4 χρόνια και 11 μήνες)

232 εμφανίσεις

1

C:
\
Program Files
\
neevia.com
\
docConverterPro
\
temp
\
NVDC
\
C91F7015
-
0838
-
4F49
-
B653
-
2AFCA420E82E
\
oculoplaniaballtown_ca9299cb
-
0173
-
4246
-
a120
-
7d569fd6f9dc.doc



Special Issue

1.
Letters to authors

2. Letters to
the
editor

3. Editor’s reply


2

C:
\
Program Files
\
neevia.com
\
docConverterPro
\
temp
\
NVDC
\
C91F7015
-
0838
-
4F49
-
B653
-
2AFCA420E82E
\
oculoplaniaballtown_ca9299cb
-
0173
-
4246
-
a120
-
7d569fd6f9dc.doc



1.
Letters to authors


Dear Dr
Name


You might be interested in contributing to the forthcoming special issue of the Journal of
Biotechnology. Contributions should relate as c
losely as possible to ‘Products of yeasts for
pharmaceutical applications’, which means your presentation at the conference might need
to be somewhat modified. First and foremost, we are looking for original research
contributions but there may also be som
e space for comprehensive review papers. The final
selection will be made from the information requested below and authors will be informed of
our decision by 22 June at the latest.


If you are interested in contributing, please forward the following info
rmation directly to me by
Monday, 9 June 2008:

exact title of your contribution

abstract max.

200 words (in British English)

author’s and co
-
authors’ names and their affiliations

date you would be able to deliver the full paper by if selected (preferabl
y June 30, if
necessary July 31).


Looking forward to hea
ring from you,

Best regards

Chris Meier



Dear
Name


First of all, I would like to thank you for all you did to set up this event. The organisation was
excellent and the topics were very interesti
ng indeed! It was a real pleasure for me to
participate in this conference
.


As the results I presented were published last year in the Journal of Biotechnology, I will not
be submitting a paper for the special issue you mentioned.


Kind regards and thanks

again

Chris Meier


3

C:
\
Program Files
\
neevia.com
\
docConverterPro
\
temp
\
NVDC
\
C91F7015
-
0838
-
4F49
-
B653
-
2AFCA420E82E
\
oculoplaniaballtown_ca9299cb
-
0173
-
4246
-
a120
-
7d569fd6f9dc.doc




Dear colleagues,


FYI the e
-
mail below. I am still waitig for the definite answer of the editor and hope to receive
it by the end of this week at the latest.


Thank you very much for your patience and in case of success we will postpon
e the
submission deadlines correspondingly.


Kind regards,

Chris Meier



Dear colleagues


I have today been in touch with the editor of Journal of Biotechnology and am writing to
inform you of the final decision.


In spite of the goodwill of everyone invo
lved, yours included, we have not been able to
secure a special issue devoted to the BioTech 2008. Although we have received many
interesting contributions, (1) a joint focus on pharmaceutical applications is difficult to arrange
and (2) only a few (four)
contributions are based on invited lectures and, thus, a special issue
is in accordance to the current editorial policy not justified.


Nevertheless, you are invited to submit your papers to J. Biotech in the usual way. An
acknowledgement that your present
ation was given at the BioTech 2008 would be much
appreciated.


With best wishes for your success and looking forward to seeing you again in Wädenswil in
2011 if not before,


Best regards,

Chris Meier

4

C:
\
Program Files
\
neevia.com
\
docConverterPro
\
temp
\
NVDC
\
C91F7015
-
0838
-
4F49
-
B653
-
2AFCA420E82E
\
oculoplaniaballtown_ca9299cb
-
0173
-
4246
-
a120
-
7d569fd6f9dc.doc



2. Letters to editor

D
ear Professor
Name


Referring t
o my first discussion with Professor
Name

during the 13th ECB in Barcelona, I
would like to make an official application for a (post
-
conference) thematic issue of the Journal
of Biotechnology dedicated to the topic of our conference, to which authors other

than the
conference participants will also be invited to contribute.


Detailed information on the scope of the BioTech2008 and the 4th Swiss
-
Czech Symposium
on Advanced Biotechnology, entitled “Biopharmaceuticals: why use yeasts?” and the
programme for th
e event on 22 and 23 May 2008 is being continuously updated on
http://www.biotech2008.ch
. Continuing in the tradition of the successful symposia held in
2005 in Wädenswil (CH) and in 1999 and 2002 in Prague (CZ), we
expect an interdisciplinary
scientific debate among experts from industry and academia on the further potential of yeast
expression systems (e.g.
Pichia pastoris
,
Yarrowia lipolytica
,
Schizosaccharomyces pombe
,
and
Hansenula polymorpha
) for manufacturing b
oth functional/therapeutic proteins (including
in the area of humanisation of proteins) and enzymes applied in the synthesis and
modification of pharmaceuticals. Furthermore, we intend to elucidate the capabilities of
combined in vivo and in vitro approach
es (i.e. interactions of expression, process control and
chemical post
-
treatment) to refine particular protein specifications.


We would highly appreciate receiving your principal decision as soon as possible to enable
us to announce this attractive publis
hing opportunity on the conference websites by mid
-
October 2007, i.e. I am kindly asking you to confirm your agreement to the final sentence
relating to scope in the Word
-
file attached.

Please also find the key data for our endeavours in this file; if req
uired, we will gladly adapt
our proposal to the editorial needs.


Thanking you in anticipation,

Yours sincerely,


Chris Meier
,

on behalf of the Scientific Committee



Dear Professor
Name and Dr

Name


5

C:
\
Program Files
\
neevia.com
\
docConverterPro
\
temp
\
NVDC
\
C91F7015
-
0838
-
4F49
-
B653
-
2AFCA420E82E
\
oculoplaniaballtown_ca9299cb
-
0173
-
4246
-
a120
-
7d569fd6f9dc.doc



Thank you both very much for your immediate responses.

As I am now travelling, I will come
back to the issues you have addressed by October 22 at the latest.


However, there is an item of confusion which we can already clarify. I was unofficially
informed that J. Biotech. distinguishes between very defined “s
pecial issues” (i.e. those
devoted a single conference only) and “thematic issues”, to which other authors interested in
the topic can also contribute.

In fact, I was initially referring to the latter in respect of our conference, but your answer
refers t
o a “special issue”. Generally speaking, would you be prepared to agree to a
“thematic issue” in this particular case or are we allowed to apply for a “special issue” only?


Thanking you in anticipation a brief reply,

Yours sincerely,

Chris Meier


Dear P
rofessor
Name


As you may remember, last autumn I asked you to devote a special issue of the Journal of
Biotechnology to the forthcoming conference “Biopharmaceuticals: why use yeasts?”, which
takes place in May 2008. However, our negotiations were put on
ice as I was not then in a
position to let you have the definitive programme.


It is now my great pleasure to inform you that the programme for this ‘European’ event (i.e.
not only Swiss
-
Czech) has been finalised and full information is already available o
n the
Internet at
http://www.biotech2008.ch/
. We are delighted with the programme, which can also
be seen on the attached pdf
-
file. Registration has already started and a number of
participants have expressed an int
erest in publishing in a special issue of the journal devoted
to this conference.


Based on the current high interest, we expect to be in a position to fill a standard size issue
of the journal, i.e. 15 full length papers and an extended editorial coverin
g approximately 120
print pages, giving an issue similar to the 132(2007) one. We provisionally anticipate being
able to publish by February 2009. I will be glad to give you further details by phone. Please
don’t hesitate to use my mobile number +41 796 25
9 589, on which I can be reached
relatively easily.


6

C:
\
Program Files
\
neevia.com
\
docConverterPro
\
temp
\
NVDC
\
C91F7015
-
0838
-
4F49
-
B653
-
2AFCA420E82E
\
oculoplaniaballtown_ca9299cb
-
0173
-
4246
-
a120
-
7d569fd6f9dc.doc



Finally, on behalf of the Organising and Scientific Committees of BioTech2008, I would now
like to resubmit our official application for a (post
-
conference) special issue of the Journal of
Biotechnology
dedicated to the topic of the conference and would be grateful if you would let
us know of your decision in the near future.


Thanking you in anticipation,

Yours sincerely,

Chris Meier


Dear Professor Name


Thank you very much for the compliments recently
paid concerning the definitive programme
of the conference entitled "Biopharmaceuticals: why use yeasts? (BioTech2008)".
Nonetheless, we are unable to share your concerns about collecting an adequate number of
high
-
quality papers in accordance with the pub
lishing plan as proposed earlier:


-

30 June 2008 (deadline for manuscript submission to the journal/reviewers);

-

30 November 2008 (completion of review and revision process);

-

February 2009 (publication of the special issue of the Journal of Biotechnolo
gy)


Already 8 contributions to a special issue of any reviewed journal devoted to this conference
(but preferably the Journal of Biotechnology) have been promised by invited speakers and a
further 3 have been confirmed by persons submitting posters, inclu
ding a contribution from
Professor Helmut Schwab’s group building on their recently published article in J. Biotech.
133 (2008) 301
-
310. In addition, as registration deadlines have not yet expired and the
conference takes place from 21 May to 23 May 2008,
the definite list of all persons interested
in publishing in the special issue will be forwarded to you by 28 May 2008 at the latest. For
the above reasons, the session chairpersons and I are confident that we will be able to
provide the minimum of 12
-
15 m
anuscripts requested.


Naturally we would like to broadcast the opportunity to publish, for instance on the
http://www.biotech2008.ch

webpage. In order to be able to do this with confidence, I would
appreciate your d
ecision on whether the February 2009 (or a following) issue will be devoted
to the topic “Biopharmaceuticals: why use yeasts?”. We trust the guarantee from both
Professor Glieder (a colleague of Professor Schwarz from Graz) and myself for a good
number of
high
-
quality contributions will help you convince the editorial board to reach a
positive decision soon.

7

C:
\
Program Files
\
neevia.com
\
docConverterPro
\
temp
\
NVDC
\
C91F7015
-
0838
-
4F49
-
B653
-
2AFCA420E82E
\
oculoplaniaballtown_ca9299cb
-
0173
-
4246
-
a120
-
7d569fd6f9dc.doc




Thank you in anticipation of an early reply, Yours sincerely,


Chris Meier
,

on behalf of the Scientific Committee



Dear Professor Name


I am sure you

will recall our exchange at the beginning of this year regarding the special
issue to be devoted to the BioTech 2008 conference. This event was a great success, as
confirmed by the unusually high number of industry participants and the presence of the
mos
t important patent and licence owners in the field.


As many of the authors want to finalise their contributions before the summer break, may I
kindly ask you to decide not later than by the end of next week on the subsequent steps (and
deadlines) to be c
ommunicated to them. Both of the possible directions would suit me, that
is, (i) either you/we invite the authors to submit their contributions to be published in any
regular issue or (ii) we decide on a special issue with clear deadlines and an appropriat
e
editorial.


The following materials should facilitate your decision:


1.

the conference materials, most of which can be downloaded at
http://www.biotech2008.ch/downloads/

(Proceedings and Press Release i
ncluded)


2.

an excel
-
list of authors willing to contribute


3.

the first draft of a paragraph to be included in the editorial (NB any comments or
suggested improvements directly typed in the attached Word
-
file would be most appreciated)


Please don’t hes
itate to phone me to facilitate the information exchange as well your
decision.


Thanking you in advance for an early reply.

Kind regards,

Chris Meier

8

C:
\
Program Files
\
neevia.com
\
docConverterPro
\
temp
\
NVDC
\
C91F7015
-
0838
-
4F49
-
B653
-
2AFCA420E82E
\
oculoplaniaballtown_ca9299cb
-
0173
-
4246
-
a120
-
7d569fd6f9dc.doc




Dear Professor Name


As I have not received a reply to my previous e
-
mail, I am wondering if it (and the

attachments) actually reached you. I’ve reprinted it below and would be grateful to have the
information requested as soon as possible.


This particularly applies to the final part since many of the authors require this before the
summer break, i.e. incl
uding the young members of Professor
Name
's group from Graz.


Thanking you for an early reply,


Yours sincerely,

Chris Meier

9

C:
\
Program Files
\
neevia.com
\
docConverterPro
\
temp
\
NVDC
\
C91F7015
-
0838
-
4F49
-
B653
-
2AFCA420E82E
\
oculoplaniaballtown_ca9299cb
-
0173
-
4246
-
a120
-
7d569fd6f9dc.doc



3. Editor’s reply


Dear Professor Name,


thank you for your mail concerning the possibilty of a special issue devoted to the BioT
ech
2008 Conference. I was unfortunetely not able to respond earlier since I was out of the office
for the last two days.

Thank you also for providing the names of authors willing to contribute to such a Special
Issue, and the topics of their contribution.

From this list I learnt that only four contributions
are based on invited lectures of the conference. This is unfortunately not sufficient for a
Special Issue of the J.Biotechnology.

As I already mentioned in an earlier mail, our Special Issues are not op
en for poster
contributions. We made the experience that the poster based manuscripts normally have no
chance to survive the review process.


Therefore, I agree with the other possibility mentioned in your mail.

The lecture based manuscripts should be subm
itted for regular issues of the
J.Biotechnology. As far as the poster presentations are concerned, they may also be
submitted if the work is suitable for preparing "complete" manuscripts.

Thus, you are invited to communicate this information to the putativ
e authors.


Sincerely yours


Chris Meier

Chief Editor